Axl-derived beta-hairpin peptides (Bristol-Myers Squibb)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameAxl-derived beta-hairpin peptides (Bristol-Myers Squibb)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAXL receptor tyrosine kinase inhibitorsGrowth arrest-specific protein 6 inhibitors
TargetsGrowth arrest-specific protein 6AXL receptor tyrosine kinase
Therapy Area/IndicationsArterial thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsArterial thrombosis

Other Information

ATC CodeN/A
Related LinksN/A